At the time of the preparation of the financial statements, our management is required to use estimates, evaluations, and assumptions which affect the application of the accounting policy and the amounts reported for assets, obligations, income, and expenses. Any estimates and assumptions are continually reviewed.
At the time of the preparation of the financial statements, our management is required to use estimates, evaluations, and assumptions which affect the application of the accounting policy and the amounts reported for assets, obligations, income, and expenses. Any estimates and assumptions are continually reviewed.
We estimate the fair value of share options granted using a Black-Scholes Merton options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are Ordinary Shares price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire).
We estimate the fair value of share options granted using the Black-Scholes-Merton options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are Ordinary Shares price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire).
If funds are not available, we may be required to delay, reduce the scope of, or eliminate research or development plans for, or commercialization efforts with respect to our products. 53 5.C Research and development, patents and licenses, etc.
If funds are not available, we may be required to delay, reduce the scope of, or eliminate research or development plans for, or commercialization efforts with respect to our products. 5.C Research and development, patents and licenses, etc.
Operating Expenses Our current operating expenses consist of three components — research and development expenses, marketing and sales expenses and general and administrative expenses. Research and development expenses, net Our research and development expenses, net consist primarily of salaries and related personnel expenses, subcontracted work and consulting and other related research and development expenses.
Operating Expenses Our current operating expenses consist of three components — research and development expenses, marketing and sales expenses and general and administrative expenses. 44 Research and development expenses, net Our research and development expenses, net consist primarily of salaries and related personnel expenses, subcontracted work and consulting and other related research and development expenses.
Investing Activities Net cash provided by investing activities of approximately $8,983,000 during the year ended December 31, 2022 was provided by changes of short-term deposits of approximately $10,297,000, offset by our investment in Rail Vision equity securities of approximately $715,000 and investment in a simple agreement for future equity (SAFE) with Rail Vision of approximately $286,000, and from purchases of fixed assets of approximately $313,000.
Net cash provided by investing activities of approximately $8,983,000 during the year ended December 31, 2022 was due to changes in short-term deposits of approximately $10,297,000, offset by our investment in Rail Vision equity securities of approximately $715,000 and investment in a simple agreement for future equity (SAFE) with Rail Vision of approximately $286,000, and from purchases of fixed assets of approximately $313,000.
The changes to the accounting estimates are credited during the period in which the change to the estimate is made. 51 B. Liquidity and Capital Resources.
The changes to the accounting estimates are credited during the period in which the change to the estimate is made. B. Liquidity and Capital Resources.
Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through debt or equity financings. We cannot be certain that additional funding will be available to us on acceptable terms, if at all.
Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through debt or equity financing. We cannot be certain that additional funding will be available to us on acceptable terms, if at all.
Our discussion and analysis for the year ended December 31, 2021 can be found in our Annual Report on Form 20-F for the fiscal year ended December 31, 2021, filed with the SEC on March 31, 2022. Overview We are a technology company engaged in the design, development and commercialization of sensor solutions for the automotive industry.
Our discussion and analysis for the year ended December 31, 2022 can be found in our Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on March 30, 2023. Overview We are a technology company engaged in the design, development and commercialization of sensor solutions for the automotive industry.
Since January 2011, we have not generated significant revenue from the sale of products, however, we expect to see an increase in our revenue from the sale of our products in the coming years, though there is no guarantee we will be successful in doing so.
We have incurred losses and generated negative cash flows from operations since January 2011. Since January 2011, we have not generated significant revenue from the sale of products, however, we expect to see an increase in our revenue from the sale of our products in the coming years, though there is no guarantee we will be successful in doing so.
Share-based compensation We apply ASC 718-10, “Share-Based Payment,” or ASC 718-10, which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees, consultants and directors including employee share options under our share plan based on estimated fair values.
Actual results could differ from those estimates. 49 Share-based compensation We apply ASC 718-10, “Share-Based Payment,” or ASC 718-10, which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees, consultants and directors including employee share options under our share plan based on estimated fair values.
The following table discloses the breakdown of sales and marketing expenses: Year ended December 31, U.S. dollars in thousands 2022 2021 Payroll and related expenses 1,318 1,273 Exhibitions, conventions and travel expenses 302 42 Consultants 558 394 Other 52 139 Total 2,230 1,848 General and administrative General and administrative expenses consist primarily of salaries and related personnel expenses, professional service fees (for accounting, legal, bookkeeping, intellectual property and facilities), directors fees and insurance and other general and administrative expenses.
The following table discloses the breakdown of sales and marketing expenses: Year ended December 31, U.S. dollars in thousands 2023 2022 Payroll and related expenses 1,076 1,318 Exhibitions, conventions and travel expenses 379 302 Consultants 416 558 Other 68 52 Total 1,939 2,230 General and administrative General and administrative expenses consist primarily of salaries and related personnel expenses, professional service fees (for accounting, legal, bookkeeping, intellectual property and facilities), directors fees and insurance and other general and administrative expenses.
Our management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgment and assumptions can affect reported amounts and disclosures made. Actual results could differ from those estimates.
Our management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgment and assumptions can affect reported amounts and disclosures made.
In that regard, we registered up to $60,000,000 of our ADSs on a Registration Statement on Form F-3 (File No. 333-252334) for the sale under the January 2021 Sales Agreement. Through March 20, 2023, we have sold an aggregate of 1,378,344 ADSs for aggregate gross proceeds of approximately $14 million.
In that regard, we registered up to $60,000,000 of our ADSs on a Registration Statement on Form F-3 (File No. 333-252334) for the sale under the January 2021 Sales Agreement. Through December 7, 2023, the date we terminated the 2021 Sales Agreement, we have sold an aggregate of 1,438,294 ADSs for aggregate gross proceeds of approximately $14.1 million.
The table below presents our cash flows for the periods indicated: December 31, U.S. dollars in thousands 2022 2021 Operating activities (17,057 ) (12,125 ) Investing activities 8,983 (12,582 ) Financing activities - 14,160 Effect of exchange rate changes on cash and cash equivalents (839 ) (37 ) Net decrease in cash and cash equivalents (8,913 ) (10,584 ) Operating Activities Net cash used in operating activities of approximately $17,057,000 during the year ended December 31, 2022 was primarily used for payment of payroll and related expenses, payments for professional services, subcontracted work and travel, patent, directors’ fees, rent and other miscellaneous expenses.
The table below presents our cash flows for the periods indicated: December 31, U.S. dollars in thousands 2023 2022 Operating activities (14,926 ) (17,057 ) Investing activities 7,092 8,983 Financing activities 4,181 - Effect of exchange rate changes on cash and cash equivalents 112 (839 ) Net decrease in cash and cash equivalents (3,541 ) (8,913 ) Operating Activities Net cash used in operating activities of approximately $14,926,000 during the year ended December 31, 2023 was primarily used for payment of payroll and related expenses, payments for professional services, subcontracted work and travel, patent, directors’ fees, rent and other miscellaneous expenses.
Overview Since our inception through December 31, 2022, we have funded our operations principally with approximately $114 million, in the aggregate, from funding from Magna, the issuance of Ordinary Shares or ADSs and exercise of warrants and options. As of December 31, 2022, we had approximately $26.5 million in cash and cash equivalents, restricted cash and short-term bank deposits.
Overview Since our inception through December 31, 2023, we have funded our operations principally with approximately $118,700,000, in the aggregate, from funding from Magna, the issuance of Ordinary Shares or ADSs and exercise of warrants and options. As of December 31, 2023, we had approximately $15.7 million in cash and cash equivalents and restricted cash.
Net loss As a result of the foregoing, our loss for the year ended December 31, 2022 was approximately $21,676,000, as compared to approximately $15,036,000 for the year ended December 31, 2021, an increase of approximately $6,640,000. We prepare our financial statements in accordance with U.S. GAAP.
Net loss As a result of the foregoing, our loss for the year ended December 31, 2023 was approximately $18,410,000, as compared to approximately $21,676,000 for the year ended December 31, 2022, a decrease of approximately $3,266,000. We prepare our financial statements in accordance with U.S. GAAP.
If we are unable to obtain additional financing or are unsuccessful in commercializing our products and securing sufficient funding, we may be required to reduce activities, curtail or even cease operations.
Any required additional capital, whether forecasted or not, may not be available on reasonable terms, or at all. If we are unable to obtain additional financing or are unsuccessful in commercializing our products and securing sufficient funding, we may be required to reduce activities, curtail or even cease operations.
The following table discloses the breakdown of general and administrative expenses: Year ended December 31, U.S. dollars in thousands 2022 2021 Payroll and related expenses 1,756 1,748 Share-based payments to service providers 215 268 Professional services 1,340 1,207 Directors fees and insurance 405 494 Travel expenses 8 — Rent and office maintenance 175 212 Other 90 51 Total 3,989 3,980 Comparison of the year ended December 31, 2022 to the year ended December 31, 2021.
The following table discloses the breakdown of general and administrative expenses: Year ended December 31, U.S. dollars in thousands 2023 2022 Payroll and related expenses 1,458 1,756 Share-based payments to service providers 134 215 Professional services 898 1,340 Directors’ fees and insurance 326 405 Travel expenses 15 8 Rent and office maintenance 196 175 Other 92 90 Total 3,119 3,989 45 Comparison of the year ended December 31, 2023 to the year ended December 31, 2022.
Critical Accounting Estimates We describe our significant accounting policies more fully in Note 2 to our financial statements for the year ended December 31, 2022. We believe that the accounting policies below are critical in order to fully understand and evaluate our financial condition and results of operations. We prepare our financial statements in accordance with U.S. GAAP.
We believe that the accounting policies below are critical in order to fully understand and evaluate our financial condition and results of operations. We prepare our financial statements in accordance with U.S. GAAP.
During 2022, our Board of Directors approved the grant of options to purchase 13,075,000 of our Ordinary Shares, subject to the terms and condition of each specific grant. 54
During 2023, our Board approved the grant of options to purchase 2,675,000 of our Ordinary Shares, subject to the terms and condition of each specific grant.
Finance expense, net for the year ended December 31, 2022, consist primarily of the revaluation of our investment in Rail Vision to its fair value in the amount of $2,208,000, from exchange rate differences in the amount of $2,194,000, offset by interest income in the amount of $189,000.
Finance expenses, net, for the year ended December 31, 2022, consisted of loss from the revaluation of the Company’s investment in Rail Vision Ltd. to its fair value in the amount of $2,208,000, and exchange rate differences and lease liabilities in the amount of $2,202,000, offset by interest income in the amount of $189,000.
The following table discloses the breakdown of research and development expenses: Year ended December 31, U.S. dollars in thousands 2022 2021 Payroll and related expenses 8,778 7,556 Subcontracted work and consulting 1,523 1,751 Share-based payments to service providers 57 118 Rent and office maintenance 1,068 810 Travel expenses 141 44 Other 362 309 Less participation in grants (395 ) (351 ) Sales of prototypes — (67 ) Total 11,534 10,170 We expect that our research and development expenses will increase as we will need to recruit more employees as we move closer to commercialization of our solutions. 49 Sales and marketing Our sales and marketing expenses consist primarily of salaries and related personnel expenses, consultants, exhibitions and travel expenses and other marketing and sales expenses.
The following table discloses the breakdown of research and development expenses: Year ended December 31, U.S. dollars in thousands 2023 2022 Payroll and related expenses 8,997 8,778 Subcontracted work and consulting 1,229 1,523 Share-based payments to service providers 19 57 Rent and office maintenance 936 1,068 Travel expenses 90 141 Other 416 362 Less participation in grants (100 ) (395 ) Total 11,587 11,534 We expect that our research and development expenses will increase as we will need to recruit more employees as we move closer to commercialization of our solutions.
Results of Operations Year ended December 31, U.S. dollars in thousands 2022 2021 Gross profit 298 53 Research and development expenses, net 11,534 10,170 Marketing and sales 2,230 1,848 General and administrative 3,989 3,980 Operating loss 17,455 15,945 Financial expenses (income), net 4,221 (909 ) Net loss 21,676 15,036 Loss attributable to holders of Ordinary Shares 21,676 15,036 50 Research and development expenses, net Our research and development expenses for the year ended December 31, 2022 amounted to $11,534,000, representing an increase of $1,364,000, or 13.4%, compared to approximately $10,170,000 for the year ended December 31, 2021.
Results of Operations Year ended December 31, U.S. dollars in thousands 2023 2022 Revenues 497 550 Gross profit 354 298 Research and development expenses, net 11,587 11,534 Marketing and sales 1,939 2,230 General and administrative 3,119 3,989 Operating loss 16,291 17,455 Financial expenses, net 2,119 4,221 Net loss 18,410 21,676 Loss attributable to holders of Ordinary Shares 18,410 21,676 Revenues Our Revenues for the year ended December 31, 2023, amounted to $497,000, representing a decrease of $53,000, or 9.6%, compared to approximately $550,0000 for the year ended December 31, 2022.
Net cash used in operating activities of approximately $12,125,000 during the year ended December 31, 2021 was primarily used for payment of payroll and related expenses, payments for professional services, subcontracted work and travel, patent, directors’ fees, rent and other miscellaneous expenses.
Net cash used in operating activities of approximately $17,057,000 during the year ended December 31, 2022 was primarily used for payment of payroll and related expenses, payments for professional services, subcontracted work and travel, patent, directors’ fees, rent and other miscellaneous expenses. 47 Investing Activities Net cash provided by investing activities of approximately $7,092,000 during the year ended December 31, 2023 was due to changes in short-term deposits of approximately $7,216,000 and for purchases of fixed assets of approximately $124,000.
Sales and marketing Our marketing and sales expenses for the year ended December 31, 2022 amounted to approximately $2,230,000, representing an increase of approximately $382,000, or 20.7%, compared to approximately $1,848,000 for the year ended December 31, 2021.
Sales and marketing Our marketing and sales expenses for the year ended December 31, 2023 amounted to approximately $1,939,000, representing a decrease of approximately $291,000, or 13%, compared to approximately $2,230,000 for the year ended December 31, 2022. The decrease is mainly attributable to a decrease in payroll and related expenses and a decrease in consultants.
General and administrative Our general and administrative expenses amounted to approximately $3,989,000 for the year ended December 31, 2022, compared to approximately $3,980,000 for the year ended December 31, 2021.
General and administrative Our general and administrative expenses amounted to approximately $3,119,000 for the year ended December 31, 2023, representing a decrease of approximately $870,000, or 22%, compared to approximately $3,989,000 for the year ended December 31, 2022. The decrease is mainly attributable to a decrease in payroll and related expenses and in professional services.
Financial expense and income, net Financial expense and income, net mainly consist of reevaluation of securities, bank interest income, exchange rate differences and other transactional costs. We recognized a financial expense, net of approximately $4,221,000 for the year ended December 31, 2022, compared to a financial income, net of $909,000 for the year ended December 31, 2021.
Operating loss As a result of the foregoing, our operating loss for the year ended December 31, 2023 was approximately $16,291,000, as compared to an operating loss of approximately $17,455,000 for the year ended December 31, 2022, a decrease of approximately $1,164,000, or 7%. 46 Financial expenses and income, net Financial expenses, net, mainly consist of revaluation of securities, bank interest income, exchange rate differences and other transactional costs.
Net cash provided by financing activities in the year ended December 31, 2021 consisted of approximately $13,508,000 provided from net proceeds from the issuance of Ordinary Shares and from exercise of options and warrants of approximately $652,000. 52 On January 22, 2021, we entered into a subsequent sales agreement with AGP, or the January 2021 Sales Agreement, pursuant to which we may offer and sell, from time to time, our ADSs.
There was no financial activity during the twelve-month period ended December 31, 2022. On January 22, 2021, we entered into a subsequent sales agreement with AGP, or the January 2021 Sales Agreement, pursuant to which we may offer and sell, from time to time, our ADSs.
As of December 31, 2022, our cash and cash equivalents including restricted cash and short-term bank deposits were approximately $26,491,000. We expect that our existing cash, cash equivalents and short-term bank deposits will be sufficient to fund our current operations through the second quarter of 2024.
As of December 31, 2023, our cash and cash equivalents including restricted cash and short-term bank deposits were approximately $15,734,000.
Operating Results— Comparison of the year ended December 31, 2022 to the year ended December 31, 2021— Research and Development Expenses, Net.” 5.D Trend Information The COVID-19 pandemic has impacted companies in Israel and around the world, and as its trajectory remains highly uncertain.
Operating Results— Comparison of the year ended December 31, 2023, to the year ended December 31, 2022— Research and Development Expenses, Net.” 5.D Trend Information 5.E. Critical Accounting Estimates We describe our significant accounting policies more fully in Note 2 to our financial statements for the year ended December 31, 2023.
Operating loss As a result of the foregoing, our operating loss for the year ended December 31, 2022 was approximately $17,455,000, as compared to an operating loss of approximately $15,945,000 for the year ended December 31, 2021, an increase of approximately $1,510,000, or 9.5%.
Research and development expenses, net Our research and development expenses for the year ended December 31, 2023 amounted to $11,587,000, representing an increase of $53,000, or 0.5%, compared to approximately $11,534,000 for the year ended December 31, 2022.
Until we can generate significant recurring revenues and achieve profitability, we may need to seek additional sources of funds through the sale of additional equity securities, debt or other securities. Any required additional capital, whether forecasted or not, may not be available on reasonable terms, or at all.
As of the date of this annual report on Form 20-F, after selling the entire investment stake in Rail Vision for approximately $1,840,000 we expect that our existing cash, cash equivalents and short-term bank deposits will be sufficient to fund our current operations through the end of the second quarter of 2025. 48 Until we can generate significant recurring revenues and achieve profitability, we may need to seek additional sources of funds through the sale of additional equity securities, debt or other securities.